SecSonar.com

CAMP4 Therapeutics Corporation (CAMP)

CAMP4 Therapeutics Corporation at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

CAMP4 Therapeutics Corporation (CAMP) is a Biotechnology company based in US with a market capitalization of $93.6M. Free cash flow was negative at -$29.8M. This page tracks CAMP's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 55 employees · IPO Oct 11, 2024

Valuation

Valuation & price

$4.31 · as of May 17, 2026 · -39.6% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

1.96

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$7.01$4.18$1.36Jul 25Dec 25Jul 26Jul 7, 25$1.41Jul 9, 25$1.52Jul 11, 25$1.50Jul 15, 25$1.44Jul 17, 25$1.66Jul 21, 25$1.59Jul 23, 25$1.69Jul 25, 25$1.81Jul 29, 25$1.67Jul 31, 25$1.63Aug 4, 25$1.64Aug 6, 25$1.52Aug 11, 25$1.36Aug 13, 25$1.46Aug 15, 25$1.67Aug 19, 25$1.71Aug 21, 25$1.59Aug 25, 25$1.56Aug 27, 25$1.51Aug 29, 25$1.52Sep 3, 25$1.41Sep 5, 25$1.52Sep 9, 25$1.99Sep 11, 25$2.78Sep 16, 25$2.77Sep 18, 25$2.50Sep 22, 25$2.75Sep 24, 25$2.79Sep 26, 25$2.98Sep 30, 25$3.00Oct 2, 25$2.98Oct 6, 25$3.45Oct 8, 25$3.54Oct 10, 25$3.71Oct 14, 25$3.38Oct 16, 25$3.11Oct 21, 25$3.41Oct 23, 25$3.48Oct 27, 25$3.90Oct 29, 25$3.86Oct 31, 25$4.16Nov 4, 25$3.77Nov 6, 25$4.45Nov 10, 25$4.16Nov 12, 25$4.39Nov 14, 25$4.10Nov 18, 25$3.95Nov 20, 25$3.51Nov 25, 25$3.38Nov 28, 25$3.80Dec 2, 25$3.31Dec 4, 25$3.39Dec 8, 25$3.65Dec 10, 25$5.72Dec 12, 25$6.49Dec 16, 25$7.01Dec 18, 25$6.21Dec 22, 25$6.00Dec 24, 25$5.92Dec 29, 25$5.99Jan 2, 26$6.00Jan 6, 26$5.99Jan 8, 26$6.20Jan 12, 26$6.04Jan 14, 26$5.92Jan 16, 26$5.62Jan 21, 26$4.50Jan 23, 26$4.01Jan 27, 26$3.83Jan 29, 26$3.87Feb 2, 26$3.78Feb 4, 26$3.54Feb 9, 26$4.33Feb 11, 26$4.68Feb 13, 26$3.85Feb 18, 26$4.01Feb 20, 26$4.34Feb 24, 26$4.70Feb 26, 26$4.49Mar 2, 26$4.42Mar 4, 26$4.08Mar 6, 26$4.20Mar 10, 26$6.05Mar 12, 26$5.38Mar 17, 26$5.55Mar 19, 26$5.16Mar 23, 26$4.69Mar 25, 26$4.75Mar 27, 26$4.31Mar 31, 26$4.41Apr 2, 26$4.47Apr 7, 26$4.65Apr 9, 26$4.49Apr 13, 26$4.64Apr 15, 26$4.59Apr 17, 26$4.49Apr 22, 26$4.56Apr 24, 26$4.44Apr 28, 26$4.27Apr 30, 26$4.17May 4, 26$3.86May 6, 26$4.06May 8, 26$4.46May 12, 26$4.50May 14, 26$4.38May 18, 26$4.56May 20, 26$4.50May 22, 26$4.51May 28, 26$4.49Jun 1, 26$4.04Jun 3, 26$4.17Jun 5, 26$4.11Jun 9, 26$4.01Jun 11, 26$4.22Jun 15, 26$3.96Jun 17, 26$4.14Jun 22, 26$4.20Jun 24, 26$4.03Jun 26, 26$4.20Jul 2, 26$4.43
$1.3652-week range$7.13
Loading valuation history…

Fundamentals

Key fundamentals

$93.6M

Market cap

—

Revenue growth (YoY)

53.1%

Gross margin

-$29.8M

Free cash flow (USD)

-$107.5M

Net debt

Net cash position

55.8%

Share dilution

1/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2017 → 2025

FY 2017$351.1MFY 2018$365.9MFY 2019$363.8MFY 2020$366.1MFY 2021$308.6MFY 2022$295.8MFY 2023$0.00FY 2024$652.0KFY 2025$3.5M
$351.1M$3.5M

Free cash flow by year

2017 → 2025

FY 2017$17.8MFY 2018$58.6MFY 2019$37.3MFY 2020$-9.8MFY 2021$17.2MFY 2022$-17.5MFY 2023$-42.6MFY 2024$-46.0MFY 2025$-29.8M
$17.8M-$29.8M

Gross margin by year

2021 → 2025

FY 202139.7%FY 202241.2%FY 2024100.0%FY 202553.1%
39.7%53.1%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 7, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventInducement Plan EstablishedJun 12, 2026Filing
  • 8-K eventPreclinical Data PresentationMay 14, 2026Filing
  • 8-K eventEarnings ReleaseMay 7, 2026Filing
  • Quarterly report10-Q FiledMay 7, 2026Filing

Questions

Frequently asked questions

What is CAMP4 Therapeutics Corporation's market cap?

CAMP4 Therapeutics Corporation (CAMP) has a market capitalization of $93.6M.

What is CAMP's P/E ratio?

A meaningful P/E ratio is not available for CAMP — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is CAMP's price-to-book (P/B) ratio?

CAMP trades at 1.96 times book value per share.

Are insiders buying CAMP stock?

SEC Form 4 filings show no open-market insider buys at CAMP4 Therapeutics Corporation in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

FBIO

Fortress Biotech, Inc.

$93.3M

ATRA

Atara Biotherapeutics, Inc.

$94.9M

ANIX

Anixa Biosciences, Inc.

$92.2M

NRXS

NeurAxis, Inc.

$89.9M

ICCC

ImmuCell Corporation

$89.6M

DTIL

Precision BioSciences, Inc.

$89.5M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.